INS and fatty liver disease: Despite palmitoleate inducing hepatic steatosis, this FA may dissociate the liver inflammatory response from hepatic steatosis, and promote insulin-sensitization and its pro-lipogenic effect, by enhancing hepatic FAS expression due to higher expression of SREBP-1c [140].